• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与免疫原性细胞死亡相关的损伤相关分子模式 (DAMPs) 在肺腺癌细胞中被临床相关化疗药物差异触发。

Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.

机构信息

Programa de Pós-Graduação em Ciências Pneumológicas, Laboratório de Pulmão e Vias Aéreas, FAMED/UFRGS, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

Departamento de Ciências Morfológicas, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.

出版信息

BMC Cancer. 2020 May 26;20(1):474. doi: 10.1186/s12885-020-06964-5.

DOI:10.1186/s12885-020-06964-5
PMID:32456685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7251700/
Abstract

BACKGROUND

Chemotherapeutics can stimulate immune antitumor response by inducing immunogenic cell death (ICD), which is activated by Damage-Associated Molecular Patterns (DAMPs) like the exposure of calreticulin (CRT) on the cell surface, the release of ATP and the secretion of High Mobility Group Box 1 (HMGB1).

METHODS

Here, we investigated the levels of ICD-associated DAMPs induced by chemotherapeutics commonly used in the clinical practice of non-small cell lung cancer (NSCLC) and the association of these DAMPs with apoptosis and autophagy. A549 human lung adenocarcinoma cells were treated with clinically relevant doses of cisplatin, carboplatin, etoposide, paclitaxel and gemcitabine. We assessed ICD-associated DAMPs, cell viability, apoptosis and autophagy in an integrated way.

RESULTS

Cisplatin and its combination with etoposide induced the highest levels of apoptosis, while etoposide was the less pro-apoptotic treatment. Cisplatin also induced the highest levels of ICD-associated DAMPs, which was not incremented by co-treatments. Etoposide induced the lower levels of ICD and the highest levels of autophagy, suggesting that the cytoprotective role of autophagy is dominant in relation to its pro-ICD role. High levels of CRT were associated with better prognosis in TCGA databank. In an integrative analysis we found a strong positive correlation between DAMPs and apoptosis, and a negative correlation between cell number and ICD-associated DAMPs as well as between autophagy and apoptosis markers. We also purpose a mathematical integration of ICD-associated DAMPs in an index (IndImunnog) that may represent with greater biological relevance this process. Cisplatin-treated cells showed the highest IndImmunog, while etoposide was the less immunogenic and the more pro-autophagic treatment.

CONCLUSIONS

Cisplatin alone induced the highest levels of ICD-associated DAMPs, so that its combination with immunotherapy may be a promising therapeutic strategy in NSCLC.

摘要

背景

化疗药物通过诱导免疫原性细胞死亡(ICD)刺激抗肿瘤免疫反应,ICD 由损伤相关分子模式(DAMPs)激活,如细胞表面钙网蛋白(CRT)的暴露、ATP 的释放和高迁移率族蛋白 1(HMGB1)的分泌。

方法

在这里,我们研究了临床上常用于非小细胞肺癌(NSCLC)的化疗药物诱导的与 ICD 相关的 DAMPs 的水平,以及这些 DAMPs 与细胞凋亡和自噬的关联。用临床相关剂量的顺铂、卡铂、依托泊苷、紫杉醇和吉西他滨处理 A549 人肺腺癌细胞。我们综合评估了与 ICD 相关的 DAMPs、细胞活力、细胞凋亡和自噬。

结果

顺铂及其与依托泊苷的联合治疗诱导了最高水平的细胞凋亡,而依托泊苷是较少促凋亡的治疗方法。顺铂还诱导了与 ICD 相关的 DAMPs 的最高水平,而联合治疗并没有增加这些 DAMPs 的水平。依托泊苷诱导了较低水平的 ICD 和最高水平的自噬,表明自噬的细胞保护作用相对于其促进 ICD 的作用占主导地位。TCGA 数据库中高 CRT 水平与较好的预后相关。在综合分析中,我们发现 DAMPs 与细胞凋亡之间存在强烈的正相关,细胞数量与与 ICD 相关的 DAMPs 以及自噬与细胞凋亡标志物之间存在负相关。我们还提出了一种将与 ICD 相关的 DAMPs 整合到一个指数(IndImmunog)中的数学方法,该指数可能更具生物学相关性。顺铂处理的细胞显示出最高的 IndImmunog,而依托泊苷是免疫原性较低和更促自噬的治疗方法。

结论

单独使用顺铂可诱导与 ICD 相关的 DAMPs 的最高水平,因此其与免疫疗法联合使用可能是 NSCLC 的一种有前途的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/f8d44c507bd0/12885_2020_6964_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/577b0935e056/12885_2020_6964_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/a4610a142172/12885_2020_6964_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/e65ca39b3fd0/12885_2020_6964_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/638048c4c1f4/12885_2020_6964_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/f8d44c507bd0/12885_2020_6964_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/577b0935e056/12885_2020_6964_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/a4610a142172/12885_2020_6964_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/e65ca39b3fd0/12885_2020_6964_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/638048c4c1f4/12885_2020_6964_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e95/7251700/f8d44c507bd0/12885_2020_6964_Fig5_HTML.jpg

相似文献

1
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.与免疫原性细胞死亡相关的损伤相关分子模式 (DAMPs) 在肺腺癌细胞中被临床相关化疗药物差异触发。
BMC Cancer. 2020 May 26;20(1):474. doi: 10.1186/s12885-020-06964-5.
2
The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.临床相关化疗药物诱导鳞状细胞癌免疫原性细胞死亡的能力。
Front Biosci (Landmark Ed). 2024 Apr 22;29(4):158. doi: 10.31083/j.fbl2904158.
3
Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death.利用免疫原性细胞死亡来撬动免疫刺激和抑制性 DAMPs 的平衡。
Nat Commun. 2020 Dec 7;11(1):6299. doi: 10.1038/s41467-020-19970-9.
4
An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.一种靶向内质网的铱(III)配合物,可诱导非小细胞肺癌发生免疫原性细胞死亡。
Angew Chem Int Ed Engl. 2021 Feb 23;60(9):4657-4665. doi: 10.1002/anie.202013987. Epub 2021 Jan 4.
5
Many faces of DAMPs in cancer therapy.DAMPs 在癌症治疗中的多面性。
Cell Death Dis. 2013 May 16;4(5):e631. doi: 10.1038/cddis.2013.156.
6
Nitric oxide water-driven immunogenic cell death: Unfolding mitochondrial dysfunction's role in sensitizing lung adenocarcinoma to ferroptosis and autophagic cell death.一氧化氮水驱动的免疫原性细胞死亡:揭示线粒体功能障碍在使肺腺癌对铁死亡和自噬性细胞死亡敏感中的作用。
Free Radic Biol Med. 2024 Sep;222:1-15. doi: 10.1016/j.freeradbiomed.2024.05.033. Epub 2024 May 18.
7
Autophagy facilitates the release of immunogenic signals following chemotherapy in 3D models of mesothelioma.自噬促进间皮瘤 3D 模型中化疗后免疫原性信号的释放。
Mol Carcinog. 2019 Oct;58(10):1754-1769. doi: 10.1002/mc.23050. Epub 2019 Jun 19.
8
Targeting immunogenic cell death in cancer.针对癌症的免疫原性细胞死亡。
Mol Oncol. 2020 Dec;14(12):2994-3006. doi: 10.1002/1878-0261.12851. Epub 2020 Dec 1.
9
Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer.化疗药物对非小细胞肺癌体外免疫检查点表达的影响。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231202307. doi: 10.1177/15330338231202307.
10
Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.临床相关化疗药物有能力诱导非小细胞肺癌免疫原性细胞死亡。
Cells. 2020 Jun 16;9(6):1474. doi: 10.3390/cells9061474.

引用本文的文献

1
Advances in cold atmospheric plasma therapy for cancer.冷大气等离子体癌症治疗的进展
Bioact Mater. 2025 Jul 25;53:433-458. doi: 10.1016/j.bioactmat.2025.07.031. eCollection 2025 Nov.
2
Targeting Frequent Efferocytosis in Tumor Microenvironment is a New Direction for Cancer Treatment.靶向肿瘤微环境中频繁发生的吞噬作用是癌症治疗的新方向。
Small Sci. 2025 Feb 4;5(4):2400479. doi: 10.1002/smsc.202400479. eCollection 2025 Apr.
3
Studying Immunogenic Cell Death in Human Colorectal Cancer Organoids.研究人类结直肠癌类器官中的免疫原性细胞死亡

本文引用的文献

1
Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment.顺铂耐药的A549非小细胞肺癌细胞可通过线粒体质量增加来识别,并且对培美曲塞治疗敏感。
Cancer Cell Int. 2019 Nov 29;19:317. doi: 10.1186/s12935-019-1037-1. eCollection 2019.
2
The Diversification of Cell Death and Immunity: Memento Mori.细胞死亡与免疫的多样化:记住死亡。
Mol Cell. 2019 Oct 17;76(2):232-242. doi: 10.1016/j.molcel.2019.09.006. Epub 2019 Oct 2.
3
The role of pyroptosis in cancer: pro-cancer or pro-"host"?
Onco Targets Ther. 2025 Jun 6;18:705-715. doi: 10.2147/OTT.S521346. eCollection 2025.
4
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902.既往未经治疗的转移性非小细胞肺癌患者接受放疗联合帕博利珠单抗加化疗的2期试验:NJLCG 1902
JTO Clin Res Rep. 2025 Feb 28;6(5):100817. doi: 10.1016/j.jtocrr.2025.100817. eCollection 2025 May.
5
A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma.一种用于光免疫疗法治疗黑色素瘤的卟啉纳米材料。
Adv Sci (Weinh). 2025 Jun;12(21):e2414592. doi: 10.1002/advs.202414592. Epub 2025 Apr 9.
6
Induction of type 2 and 3 deiodinase in the blood cells of critically ill patients.危重症患者血细胞中2型和3型脱碘酶的诱导作用。
Endocr Connect. 2025 Mar 14;14(4). doi: 10.1530/EC-24-0677. Print 2025 Apr 1.
7
Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach.通过靶向CD44的纳米颗粒增强紫杉醇和土木香内酯对结直肠癌的化学免疫治疗:一种STAT3信号通路调节方法。
Asian J Pharm Sci. 2025 Feb;20(1):100993. doi: 10.1016/j.ajps.2024.100993. Epub 2024 Nov 12.
8
The Extra-Tumoral Vaccine Effects of Apoptotic Bodies in the Advancement of Cancer Treatment.凋亡小体在癌症治疗进展中的肿瘤外疫苗效应
Small. 2025 Mar;21(9):e2410503. doi: 10.1002/smll.202410503. Epub 2025 Jan 28.
9
Etoposide as a Key Therapeutic Agent in Lung Cancer: Mechanisms, Efficacy, and Emerging Strategies.依托泊苷作为肺癌的关键治疗药物:作用机制、疗效及新策略
Int J Mol Sci. 2025 Jan 18;26(2):796. doi: 10.3390/ijms26020796.
10
Cell-membrane targeting sonodynamic therapy combination with FSP1 inhibition for ferroptosis-boosted immunotherapy.细胞膜靶向声动力疗法联合FSP1抑制用于增强铁死亡的免疫治疗。
Mater Today Bio. 2024 Dec 15;30:101407. doi: 10.1016/j.mtbio.2024.101407. eCollection 2025 Feb.
细胞焦亡在癌症中的作用:促癌还是促“宿主”?
Cell Death Dis. 2019 Sep 9;10(9):650. doi: 10.1038/s41419-019-1883-8.
4
CCPG1, a cargo receptor required for reticulophagy and endoplasmic reticulum proteostasis.CCPG1,一种用于网质体自噬和内质网蛋白平衡的货物受体。
Autophagy. 2018;14(6):1090-1091. doi: 10.1080/15548627.2018.1441473. Epub 2018 Jun 19.
5
The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.HMGB1在肺癌中的作用、机制及其潜在的治疗意义。
Oncol Lett. 2018 May;15(5):6799-6805. doi: 10.3892/ol.2018.8215. Epub 2018 Mar 8.
6
The role of high-mobility group protein box 1 in lung cancer.高迁移率族蛋白 box1 在肺癌中的作用。
J Cell Biochem. 2018 Aug;119(8):6354-6365. doi: 10.1002/jcb.26837. Epub 2018 Apr 17.
7
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.细胞死亡的分子机制:细胞死亡命名委员会 2018 年的建议。
Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23.
8
Plasma membrane changes during programmed cell deaths.程序性细胞死亡过程中的质膜变化。
Cell Res. 2018 Jan;28(1):9-21. doi: 10.1038/cr.2017.133. Epub 2017 Oct 27.
9
The human protein atlas: A spatial map of the human proteome.人类蛋白质图谱:人类蛋白质组的空间图谱。
Protein Sci. 2018 Jan;27(1):233-244. doi: 10.1002/pro.3307. Epub 2017 Oct 10.
10
The apoptotic and genomic studies on A549 cell line induced by silver nitrate.硝酸银诱导A549细胞系的凋亡及基因组研究。
Tumour Biol. 2017 Apr;39(4):1010428317695033. doi: 10.1177/1010428317695033.